We have located links that may give you full text access.
ENGLISH ABSTRACT
JOURNAL ARTICLE
[Prophylaxis of tromboembolic disease after total hip replacement.].
Total hip replacement represents an operation with high risk of thromboembolic disease. An optimal strategy of thromboprophylaxis is very important. In our two groups of patients we compared two ways of prophylaxis both during hospitalization and after hospital discharge. 81 patients in the first group were treated with low molecular weight heparin (LMWH) - Fraxiparine during the stay in hospital and with a combination of three drugs - Aspirin, Curantyl and Secatoxin during 3 months after operation. 85 patients in the second group were also treated with LMWH during the stay in hospital but LMWH was early changed for Warfarin. Warfarin was taken 3 months after operation. We assessed the occurence of clinical manifest thrombotic events-deep venous thrombosis and pulmonary embolism confirmed by Doppler ultrasonography and perfusion lung scanning. Manifest clinical thrombosis did not occur during hospitalization in the first group of patients but two thrombosis were proven in the second group. Bleeding complications were assessed as well. These complications occurred in two patients during the stay in hospital in the first group, and in three patients in the second group. None of our patients in both groups suffered from a late occurrence of clinically significant thrombosis. Currently we recommend the administration of LMWH during hospitalization, and elastis stockings to all patients after hospital discharge. Patients with higher risk of thrombosis take Warfarin 3 months after operation. Key words: thromboembolic disease, prophylaxis, low molecular weight heparin, total hip replacement.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app